Yoshiaki Fujimori - May 5, 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
4
Date filed
5/6/2022, 05:06 PM
Previous filing
May 10, 2021
Next filing
May 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Award $0 +4.88K +17.5% $0.00 32.8K May 5, 2022 Common Stock 4.88K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Reflects a value of $205,000 divided by the closing price of common stock on the date of grant.
F3 Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.

Remarks:

fujimoripoa.txt